Aurinia Pharmaceuticals Insider Trades
NASDAQ: AUPHHealth CareBiotechnology: Pharmaceutical PreparationsUSD
At close: Oct 9, 4:00 PM ET · Delayed 15 min
Last 12 months
- Purchases
- 11 · $25.14M
- Sales
- 2 · $546.37K
- Shares bought / sold
- 1.71M / 32.91K
- Net activity
- Net buying $24.6 million
Aurinia Pharmaceuticals insider activity
Over the last 12 months, Aurinia Pharmaceuticals insiders reported 41 transactions on SEC Form 4: 11 open-market purchases and 2 sales. Insiders bought $25.1 million and sold $546,373 worth of stock, for net insider buying of $24.6 million. The largest seller was Robertson Stephen P., with $546,373 in reported sales.
The most recent filing shows Robertson Stephen P. (Chief Legal Officer) selling 11,939 shares at $15.95 on Sep 10, 2026. Insider sales are common for compensation, tax and diversification reasons, while open-market purchases are rarer; tracking both helps put AUPH's ownership changes in context.
Summary generated from market data by MetaCap's automated system. Methodology
AUPH insider transactions
| Date | Insider | Type | Shares | Value | Filing |
|---|---|---|---|---|---|
| Sep 10, 2026 | Robertson Stephen P.Chief Legal Officer | Sale | 11,939 | $190.43K | Form 4 |
| Aug 21, 2026 | Robertson Stephen P.Chief Legal Officer | Sale | 20,975 | $355.95K | Form 4 |
| Jun 2, 2026 | TANG KEVIN & TANG CAPITAL MANAGEMENT LLCChief Executive Officer | Buy | 206,005 | $3.15M | Form 4 |
| Jun 1, 2026 | TANG KEVIN & TANG CAPITAL MANAGEMENT LLCChief Executive Officer | Buy | 99 | $1.52K | Form 4 |
| Jun 1, 2026 | TANG KEVIN & TANG CAPITAL MANAGEMENT LLCChief Executive Officer | Buy | 343,521 | $5.25M | Form 4 |
| May 29, 2026 | TANG KEVIN & TANG CAPITAL MANAGEMENT LLCChief Executive Officer | Buy | 262,682 | $4.02M | Form 4 |
| May 29, 2026 | TANG KEVIN & TANG CAPITAL MANAGEMENT LLCChief Executive Officer | Buy | 2,299 | $35.29K | Form 4 |
| May 18, 2026 | Robertson Stephen P.Chief Legal Officer | Award | 115,541 | — | Form 4 |
| May 18, 2026 | Cole RyanChief Operating Officer | Award | 116,144 | — | Form 4 |
| May 18, 2026 | Hearne Michael SChief Financial Officer | Award | 116,144 | — | Form 4 |
| Mar 6, 2026 | Keenan GregSVP, Chief Medical Officer | Tax withholding | 8,069 | $115.55K | Form 4 |
| Mar 3, 2026 | TANG KEVINDirector | Buy | 184,208 | $2.62M | Form 4 |
| Mar 2, 2026 | Robertson Stephen P.EVP, General Counsel | Tax withholding | 36,525 | $519.02K | Form 4 |
| Mar 2, 2026 | Donley Matthew MaxwellChief Operating Officer | Tax withholding | 40,761 | $579.21K | Form 4 |
| Mar 2, 2026 | TANG KEVINDirector | Buy | 115,792 | $1.65M | Form 4 |
| Mar 2, 2026 | TANG KEVINDirector | Buy | 83,561 | $1.20M | Form 4 |
| Mar 2, 2026 | Greenleaf PeterChief Executive Officer | Tax withholding | 100,890 | $1.43M | Form 4 |
| Mar 2, 2026 | Miller Joseph MChief Financial Officer | Tax withholding | 37,511 | $533.03K | Form 4 |
| Feb 27, 2026 | Robertson Stephen P.EVP, General Counsel | Award | 59,090 | — | Form 4 |
| Feb 27, 2026 | Donley Matthew MaxwellChief Operating Officer | Award | 58,160 | — | Form 4 |
| Feb 27, 2026 | TANG KEVINDirector | Buy | 1,600 | $23.01K | Form 4 |
| Feb 27, 2026 | TANG KEVINDirector | Buy | 214,839 | $3.03M | Form 4 |
| Feb 27, 2026 | TANG KEVINDirector | Buy | 300,000 | $4.17M | Form 4 |
| Feb 27, 2026 | Keenan GregSVP, Chief Medical Officer | Award | 40,586 | — | Form 4 |
| Feb 27, 2026 | Greenleaf PeterChief Executive Officer | Award | 196,403 | — | Form 4 |
| Feb 27, 2026 | Miller Joseph MChief Financial Officer | Award | 57,229 | — | Form 4 |
| Feb 20, 2026 | Robertson Stephen P.EVP, General Counsel | Tax withholding | 34,638 | $498.79K | Form 4 |
| Feb 20, 2026 | Miller Joseph MChief Financial Officer | Tax withholding | 32,424 | $466.91K | Form 4 |
| Feb 20, 2026 | Greenleaf PeterChief Executive Officer | Tax withholding | 100,171 | $1.44M | Form 4 |
| Feb 20, 2026 | Donley Matthew MaxwellChief Operating Officer | Tax withholding | 32,901 | $473.77K | Form 4 |
| Feb 2, 2026 | Keenan GregSVP, Chief Medical Officer | Tax withholding | 11,552 | $167.85K | Form 4 |
| Jan 2, 2026 | Miller Joseph MChief Financial Officer | Tax withholding | 40,161 | $640.57K | Form 4 |
| Jan 2, 2026 | Miller Joseph MChief Financial Officer | Award | 49,038 | — | Form 4 |
| Jan 2, 2026 | Donley Matthew MaxwellChief Operating Officer | Tax withholding | 42,787 | $682.45K | Form 4 |
| Jan 2, 2026 | Donley Matthew MaxwellChief Operating Officer | Award | 54,166 | — | Form 4 |
| Jan 2, 2026 | Greenleaf PeterChief Executive Officer | Tax withholding | 113,169 | $1.81M | Form 4 |
| Jan 2, 2026 | Greenleaf PeterChief Executive Officer | Award | 165,384 | — | Form 4 |
| Jan 2, 2026 | Robertson Stephen P.EVP, General Counsel | Tax withholding | 40,385 | $644.14K | Form 4 |
| Jan 2, 2026 | Robertson Stephen P.EVP, General Counsel | Award | 48,558 | — | Form 4 |
| Nov 21, 2025 | Bailey Jeffrey AllenDirector | Tax withholding | 2,716 | $42.59K | Form 4 |
| Nov 21, 2025 | Johnson Craig ADirector | Tax withholding | 6,039 | $94.69K | Form 4 |
| Aug 5, 2025 | TANG KEVINDirector | Buy | 200,000 | $2.34M | Form 4 |
| Aug 4, 2025 | TANG KEVINDirector | Buy | 100,000 | $1.13M | Form 4 |
| Aug 1, 2025 | Keenan GregChief Medical Officer | Sale | 20,000 | $210.00K | Form 4 |
| Aug 1, 2025 | TANG KEVINDirector | Buy | 1,000,000 | $10.12M | Form 4 |
| Mar 7, 2025 | Keenan GregChief Medical Officer | Sale | 8,305 | $68.35K | Form 4 |
| Mar 4, 2025 | Donley Matthew MaxwellChief Operating Officer | Sale | 58,991 | $467.21K | Form 4 |
| Mar 4, 2025 | Miller Joseph MChief Financial Officer | Sale | 56,154 | $444.74K | Form 4 |
| Mar 4, 2025 | Greenleaf PeterChief Executive Officer | Sale | 164,947 | $1.31M | Form 4 |
| Mar 4, 2025 | Robertson Stephen P.EVP, General Counsel | Sale | 57,607 | $456.25K | Form 4 |
| Mar 3, 2025 | Donley Matthew MaxwellChief Operating Officer | Sale | 65,902 | $527.22K | Form 4 |
| Mar 3, 2025 | Donley Matthew MaxwellChief Operating Officer | Award | 135,567 | — | Form 4 |
| Mar 3, 2025 | Miller Joseph MChief Financial Officer | Sale | 61,859 | $494.87K | Form 4 |
| Mar 3, 2025 | Miller Joseph MChief Financial Officer | Award | 114,711 | — | Form 4 |
| Mar 3, 2025 | Keenan GregChief Medical Officer | Sale | 12,239 | $97.91K | Form 4 |
| Mar 3, 2025 | Greenleaf PeterChief Executive Officer | Sale | 195,593 | $1.56M | Form 4 |
| Mar 3, 2025 | Greenleaf PeterChief Executive Officer | Award | 333,705 | — | Form 4 |
| Mar 3, 2025 | Robertson Stephen P.EVP, General Counsel | Sale | 64,872 | $518.98K | Form 4 |
| Mar 3, 2025 | Robertson Stephen P.EVP, General Counsel | Award | 102,406 | — | Form 4 |
| Feb 28, 2025 | Donley Matthew MaxwellChief Operating Officer | Award | 82,781 | — | Form 4 |
| Feb 28, 2025 | Miller Joseph MChief Financial Officer | Award | 81,457 | — | Form 4 |
| Feb 28, 2025 | Keenan GregChief Medical Officer | Award | 62,583 | — | Form 4 |
| Feb 28, 2025 | Greenleaf PeterChief Executive Officer | Award | 290,728 | — | Form 4 |
| Feb 28, 2025 | Robertson Stephen P.EVP, General Counsel | Award | 84,106 | — | Form 4 |
Transaction codes follow SEC Form 4: P = open-market purchase, S = open-market sale, A = grant or award, M = option exercise, F = shares withheld for taxes. About Form 4